Reprint
Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
Edited by
September 2019
230 pages
- ISBN978-3-03921-451-8 (Paperback)
- ISBN978-3-03921-452-5 (PDF)
This book is a reprint of the Special Issue Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA) that was published in
Biology & Life Sciences
Medicine & Pharmacology
Summary
This Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, France) (Nice, September 2018). The central theme of JMLC is to discuss new advances and exchange ideas regarding lung cancer. Notably, the talks covered different topics on new therapeutic strategies (targeted therapy and immuno-oncology), molecular and cellular biology, biomarkers, and the epidemiology of lung cancer. Special attention was also given to lung cancer in elderly patients. The articles published in this Special Issue covered subjects such as the assessment of new biomarkers and new approaches for the early detection of lung cancer, epidemiological data, and emphasized a place for the newly characterized cellular pathways in lung cancer, which opens room for therapeutic perspectives for lung cancer patients.
Format
- Paperback
License
© 2019 by the authors; CC BY-NC-ND license
Keywords
cancer; older adults; geriatric assessment; geriatric interventions; non-small cell lung cancer; non-smoker; tumor microenvironment; targeted treatment; lung cancer; artificial intelligence; screening; lncRNA; MALAT1; metastasis; bioinformatics; integrated approaches; lung cancer; rational therapy; immune profiling; cancer tissues; multiplexed methodologies; image analysis; spatial analysis; aging; cancer; optimization; research; education; elderly; well-being; circulating tumor cells; liquid biopsy; lung cancer; personal medicine; techniques; xenograft; multiplexed; brightfield; chromogenic; fluorescence; molecular; immune profiling; immune-oncology; digital; lung cancer; lung adenocarcinoma; macrophage; immunotherapy; interleukin-1β and immunometabolism; lung cancer; EGFR mutations; EGFR TKIs; non-coding RNAs; microRNAs; long non-coding RNAs; hormones; hormone-like action; non-small cell lung cancer; immunotherapy; PD-1/PD-L1 checkpoint blockade; CD8 T Cells; immune blockade; NSCLC; reversal of EMT; tumor microenvironment; tumor plasticity; TNBC